Boston Scientific SVP exercises RSUs, withholds shares

Boston Scientific senior vice president and chief HR officer Miriam O'Sullivan reported multiple equity award transactions in mid‑February.

Rhea-AI Filing Summary

Boston Scientific senior vice president and chief HR officer Miriam O'Sullivan reported multiple equity award transactions in mid‑February. She exercised restricted stock units into 588, 1,124, and 990 shares of common stock on February 13, 14, and 16, 2026 at a price of $0.00 per share.

To cover tax obligations, she disposed of 200, 329, and 291 common shares on the same dates through tax‑withholding transactions at $74.73 per share. After these moves, she directly held 17,302 Boston Scientific shares and indirectly held 1,731 shares through her spouse.

Insider Trade Summary

2,702 shares exercised/converted

Exercise 10 txns

Insider O'Sullivan Miriam

Role SVP, Chief HR Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	990	$0.00	$0.00
Exercise	Common Stock	990	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	291	$74.73	$22K
Exercise	Restricted Stock Units	1,124	$0.00	$0.00
Exercise	Common Stock	1,124	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	329	$74.73	$25K
Exercise	Restricted Stock Units	588	$0.00	$0.00
Exercise	Common Stock	588	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	200	$74.73	$15K
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 2,891 contracts (Direct); Common Stock — 17,302 shares (Direct); Common Stock — 1,731 shares (Indirect, By Spouse)

Footnotes (4)

1. F1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
2. F2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
3. F3. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
4. F4. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did BSX executive Miriam O'Sullivan report?

Miriam O'Sullivan reported exercising restricted stock units and related tax-withholding dispositions. She converted RSUs into Boston Scientific common shares on February 13, 14, and 16, 2026, and had shares withheld at $74.73 per share to satisfy tax liabilities tied to those equity awards.

How many Boston Scientific (BSX) shares did Miriam O'Sullivan acquire through RSU exercises?

She acquired 588, 1,124, and 990 Boston Scientific common shares via RSU exercises. These derivative exercises occurred on February 13, 14, and 16, 2026, at $0.00 per share, reflecting the conversion of previously granted restricted stock units into common stock.

What tax-withholding share dispositions did the BSX SVP report?

She reported tax-withholding dispositions of 200, 329, and 291 BSX shares. These transactions, coded "F", occurred on February 13, 14, and 16, 2026 at $74.73 per share to pay exercise price or tax liabilities associated with her equity award settlements.

What are Miriam O'Sullivan's Boston Scientific share holdings after these transactions?

After the transactions, she directly held 17,302 BSX shares. The filing also shows an additional 1,731 Boston Scientific common shares held indirectly "By Spouse," reflecting separate ownership that is reported as indirect beneficial ownership.

How do the BSX restricted stock units reported by O'Sullivan convert into shares?

Each restricted stock unit represents a commitment to issue one BSX common share. Footnotes state that shares will be issued in four equal annual installments beginning on specific February anniversaries of the grant dates, aligning with the company’s standard vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 05:58 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Sullivan Miriam

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH MA 01752-1234

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief HR Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		M		588	A	$0.0000(1)	16,008	D
Common Stock	02/13/2026		F		200	D	$74.73	15,808	D
Common Stock	02/14/2026		M		1,124	A	$0.0000(1)	16,932	D
Common Stock	02/14/2026		F		329	D	$74.73	16,603	D
Common Stock	02/16/2026		M		990	A	$0.0000(1)	17,593	D
Common Stock	02/16/2026		F		291	D	$74.73	17,302	D
Common Stock								1,731	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/13/2026		M			588	(2)	02/13/2029(2)	Common Stock	588	$0.0000	1,767	D
Restricted Stock Units	(1)	02/14/2026		M			1,124	(3)	02/14/2027(3)	Common Stock	1,124	$0.0000	1,124	D
Restricted Stock Units	(1)	02/16/2026		M			990	(4)	02/16/2026(4)	Common Stock	990	$0.0000	0.0000	D

Explanation of Responses:

1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.

3. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.

4. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.

	/s/ Susan Thompson, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.